A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma

Giampietro Gasparini, Patrizia Boracchi, Pierantonio Bevilacqua, Maura Mezzetti, Franco Pozza, Noel Weidner

Research output: Contribution to journalArticle

Abstract

Epidermal growth factor receptor (EGFR) is a potentially useful new biological prognostic and predictive indicator in human breast cancer. Additional research on EGFR is warranted to enhance our information on: i) the method of choice for its detection and quality control issues; ii) its association with novel pathobiological markers of prognosis; iii) its prognostic value in multivariate analysis; and iv) its capability to predict response to hormone therapy and, in the future, to biological treatments using antibodies against the specific receptor or its ligands. In the present study we update previous data on EGFR status, determined immunocytochemically, by prolonging the period of observation up to 5 years and by including, in the multivariate analysis, several new biological indicators. The main results obtained are: i) EGFR is weakly associated with Ki-67 score (p=0.073) and with p53 expression (p=0.06); ii) EGFR is a significant indicator for recurrence (p

Original languageEnglish
Pages (from-to)59-71
Number of pages13
JournalBreast Cancer Research and Treatment
Volume29
Issue number1
DOIs
Publication statusPublished - Jan 1994

Fingerprint

Epidermal Growth Factor Receptor
Breast Neoplasms
Multivariate Analysis
Quality Control
Observation
Hormones
Ligands
Recurrence
Antibodies
Research
Therapeutics

Keywords

  • breast cancer
  • epidermal growth factor receptor
  • immunocytochemistry
  • prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma. / Gasparini, Giampietro; Boracchi, Patrizia; Bevilacqua, Pierantonio; Mezzetti, Maura; Pozza, Franco; Weidner, Noel.

In: Breast Cancer Research and Treatment, Vol. 29, No. 1, 01.1994, p. 59-71.

Research output: Contribution to journalArticle

Gasparini, Giampietro ; Boracchi, Patrizia ; Bevilacqua, Pierantonio ; Mezzetti, Maura ; Pozza, Franco ; Weidner, Noel. / A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma. In: Breast Cancer Research and Treatment. 1994 ; Vol. 29, No. 1. pp. 59-71.
@article{e679163623de4d419531f15f88268cb6,
title = "A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma",
abstract = "Epidermal growth factor receptor (EGFR) is a potentially useful new biological prognostic and predictive indicator in human breast cancer. Additional research on EGFR is warranted to enhance our information on: i) the method of choice for its detection and quality control issues; ii) its association with novel pathobiological markers of prognosis; iii) its prognostic value in multivariate analysis; and iv) its capability to predict response to hormone therapy and, in the future, to biological treatments using antibodies against the specific receptor or its ligands. In the present study we update previous data on EGFR status, determined immunocytochemically, by prolonging the period of observation up to 5 years and by including, in the multivariate analysis, several new biological indicators. The main results obtained are: i) EGFR is weakly associated with Ki-67 score (p=0.073) and with p53 expression (p=0.06); ii) EGFR is a significant indicator for recurrence (p",
keywords = "breast cancer, epidermal growth factor receptor, immunocytochemistry, prognosis",
author = "Giampietro Gasparini and Patrizia Boracchi and Pierantonio Bevilacqua and Maura Mezzetti and Franco Pozza and Noel Weidner",
year = "1994",
month = "1",
doi = "10.1007/BF00666182",
language = "English",
volume = "29",
pages = "59--71",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York LLC",
number = "1",

}

TY - JOUR

T1 - A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma

AU - Gasparini, Giampietro

AU - Boracchi, Patrizia

AU - Bevilacqua, Pierantonio

AU - Mezzetti, Maura

AU - Pozza, Franco

AU - Weidner, Noel

PY - 1994/1

Y1 - 1994/1

N2 - Epidermal growth factor receptor (EGFR) is a potentially useful new biological prognostic and predictive indicator in human breast cancer. Additional research on EGFR is warranted to enhance our information on: i) the method of choice for its detection and quality control issues; ii) its association with novel pathobiological markers of prognosis; iii) its prognostic value in multivariate analysis; and iv) its capability to predict response to hormone therapy and, in the future, to biological treatments using antibodies against the specific receptor or its ligands. In the present study we update previous data on EGFR status, determined immunocytochemically, by prolonging the period of observation up to 5 years and by including, in the multivariate analysis, several new biological indicators. The main results obtained are: i) EGFR is weakly associated with Ki-67 score (p=0.073) and with p53 expression (p=0.06); ii) EGFR is a significant indicator for recurrence (p

AB - Epidermal growth factor receptor (EGFR) is a potentially useful new biological prognostic and predictive indicator in human breast cancer. Additional research on EGFR is warranted to enhance our information on: i) the method of choice for its detection and quality control issues; ii) its association with novel pathobiological markers of prognosis; iii) its prognostic value in multivariate analysis; and iv) its capability to predict response to hormone therapy and, in the future, to biological treatments using antibodies against the specific receptor or its ligands. In the present study we update previous data on EGFR status, determined immunocytochemically, by prolonging the period of observation up to 5 years and by including, in the multivariate analysis, several new biological indicators. The main results obtained are: i) EGFR is weakly associated with Ki-67 score (p=0.073) and with p53 expression (p=0.06); ii) EGFR is a significant indicator for recurrence (p

KW - breast cancer

KW - epidermal growth factor receptor

KW - immunocytochemistry

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=0028269324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028269324&partnerID=8YFLogxK

U2 - 10.1007/BF00666182

DO - 10.1007/BF00666182

M3 - Article

C2 - 7912568

AN - SCOPUS:0028269324

VL - 29

SP - 59

EP - 71

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -